Clinical Trial Update: A Clinical Trial With KJ103 in Anti-GBM Disease [Phase 2]

View source ↗

Summary

This entry provides an update on a Phase 2 clinical trial of KJ103 for anti-glomerular basement membrane disease. The study is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anti-glomerular Basement Membrane Disease

Drugs mentioned

• KJ103

Snippet

Sponsor: Shanghai Bao Pharmaceuticals Co., Ltd. | Conditions: Anti-Glomerular Basement Membrane Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING